Brind.

MultiValent Biotherapies licensed MVB-101 from Coherent. The company plans to conduct Phase 1b/2a trials in the US.

1 report, 1 independent Updated Jun 16

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Coherent

Keep exploring

The entities involved

Coherent
operating system
- Nvidia and Coherent are partnering on AI infrastructure upgrades as the administration implements new export controls on AI companies.Mon 04:03
- An administration signals a reversal on AI regulation, coinciding with a partnership on AI infrastructure upgrades and a factory groundbreaking near Dallas.Mon 04:00

Coverage

Newest first; wire copies grouped

Jun 16manilatimes.net